Journal article icon

Journal article

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.

Abstract:

BACKGROUND AND AIMS: Cumulative safety and tolerability of budesonide MMX(®), a once-daily oral corticosteroid for inducing mild to moderate ulcerative colitis remission, was examined. METHODS: Data from three randomized, double-blind, placebo-controlled, phase II or III studies (budesonide MMX 9 mg, 6 mg, or 3 mg for 8 weeks); one phase II study (randomization to budesonide MMX 9 mg or placebo for 4 weeks, then open-label budesonide MMX 9 mg for 4 weeks); and one open-label study (budesonide...

Expand abstract
Publication status:
Published
Peer review status:
Peer Reviewed

Actions


Access Document


Publisher copy:
10.1093/ecco-jcc/jjv101

Authors


Lichtenstein, GR More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Experimental Medicine Division,
D'Haens, G More by this author
Expand authors...
Publisher:
Oxford University Press Publisher's website
Journal:
Journal of Crohn's and colitis
Publication date:
2015-06-20
DOI:
EISSN:
1876-4479
ISSN:
1873-9946
URN:
uuid:dd98c5ca-803b-4cae-8e08-43c9ae3d94db
Source identifiers:
528631
Local pid:
pubs:528631

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP